Amanote Research
Register
Sign In
Impact of Pretransplant Comorbidities on Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Hematopoietic SCT for Patients With High-Risk Myelodysplastic Syndrome and AML
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/bmt.2009.236
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
September 21, 2009
Authors
Z Y Lim
W Ingram
R Brand
A Ho
M Kenyon
S Devereux
J Marsh
G J Mufti
A Pagliuca
Publisher
Springer Science and Business Media LLC
